From: The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
BPH/Norm Vs CaP | BPH/Norm Vs Met | CaP Vs Met | Fold Change: LNCAP | Fold Change: LNCaP C4-2B | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Gene Symbol | Mean | S.D. | Mean | S.D. | Mean | S.D. | Mean | S.D. | Mean | S.D. |
activated leucocyte cell adhesion molecule | ALCAM | 2.34 | 0.86 | 1.19 | 0.76 | 1.97 | 0.84 | 1.04 | 0.68 | 1.19 | 1.47 |
cadherin 11, type 2, OB-cadherin (osteoblast) | CDH11 | 2.76 | 0.20* | 1.01 | 0.27* | 2.80 | 0.27* | -1.09 | 1.17 | -1.38 | 0.65 |
cadherin 3, type 1, P-cadherin (placental) | CDH3 | 3.07 | 0.27 | 1.11 | 0.35 | 2.87 | 0.38 | -1.19 | 0.57 | -1.06 | 0.76 |
cadherin 5, type 2, VE-cadherin (vascular epithelium) | CDH5 | 1.00 | 0.37 | 3.50 | 1.01 | 1.00 | 0.82 | -1.03 | 0.95 | -1.12 | 1.23 |
CD 3G antigen, gamma polypeptide (TiT3 complex) | CD3G | 2.11 | 0.22 | 1.12 | 0.21 | 1.90 | 0.27 | -1.07 | 0.68 | 1.01 | 0.91 |
CD 8 antigen, alpha polypeptide (p32) | CD8A | 3.24 | 0.24 | 1.05 | 0.24* | 3.15 | 0.25 | -1.38 | 0.60 | 1.26 | 0.93 |
CD 34 antigen | CD34 | 3.56 | 0.15 | 1.20 | 0.16 | 2.94 | 0.16 | -1.65 | 0.85 | 1.21 | 0.62 |
CD 36 antigen (collagen type I/thrombospondin receptor) | CD36 | 1.96 | 0.21 | 1.32 | 0.33* | 1.47 | 0.37* | 1.19 | 1.07 | 1.02 | 0.47 |
CD 53 antigen | CD53 | 2.17 | 0.43* | 0.56 | 0.45 | 3.84 | 0.24 | -1.05 | 0.85 | -1.02 | 1.06 |
CD 68 antigen | CD68 | 3.31 | 0.28 | 1.04 | 0.25 | 3.14 | 0.23 | -1.43 | 0.55 | 1.02 | 0.31 |
CD 79A antigen (immunoglobulin-associated alpha) | CD79A | 3.83 | 0.25 | 1.27 | 0.26* | 2.98 | 0.23* | 1.19 | 0.54 | -1.25 | 0.64 |
CD 151 antigen | CD151 | 2.10 | 0.18 | 0.88 | 0.16 | 2.36 | 0.17* | 1.10 | 0.92 | -1.14 | 0.81 |
CD 164 antigen, sialomucin | CD164 | 2.42 | 0.50 | 0.68 | 0.52* | 3.58 | 0.28* | 1.32 | 0.65* | 1.95 | 0.49* |
endothelial cell-specific molecule 1 | EMAP1 | 3.01 | 0.24 | 1.18 | 0.30 | 2.61 | 0.34* | -3.61 | 2.14 | -2.23 | 0.36 |
integrin, alpha 1 | ITGA1 | 1.72 | 0.60* | 0.43 | 0.70* | 4.09 | 0.34* | -1.05 | 1.20 | -1.20 | 0.62 |
integrin, alpha 2 (CD49B, subunit of VLA-2 receptor) | ITGA2 | 2.06 | 0.52* | 0.53 | 0.56* | 3.93 | 0.26 | 1.10 | 1.84 | -1.11 | 0.97 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | ITGB3 | 2.46 | 0.15 | 1.08 | 0.15 | 2.37 | 0.12 | -1.07 | 1.00 | 1.06 | 0.37* |
integrin, beta 4 | ITGB4 | 3.22 | 0.24* | 0.62 | 0.27 | 4.53 | 0.21 | -1.04 | 0.73 | -1.34 | 0.59 |
integrin, beta 5 | ITGB5 | 2.60 | 0.20 | 1.18 | 0.22 | 2.19 | 0.19 | 1.09 | 1.11 | 1.01 | 1.11 |
integrin, alpha 8 | ITGA8 | 2.09 | 0.41 | 0.48 | 0.32 | 4.12 | 0.23 | 1.14 | 0.51 | 1.01 | 0.87 |
integrin, alpha V (vitronectin receptor, CD51) | ITGAV | 2.10 | 1.53 | 0.35 | 1.40 | 5.45 | 0.16* | 1.19 | 0.44* | 1.37 | 0.29 |
integrin, alpha L (antigen CD11A) | ITGAL | 3.48 | 0.15 | 0.90 | 0.16 | 3.82 | 0.91 | -1.17 | 0.68 | 1.24 | 0.53 |
protocadherin 1 (cadherin-like 1) | PCDH1 | 4.36 | 0.24 | 0.94 | 0.28 | 4.32 | 0.28 | -1.48 | 0.37 | 1.17 | 0.46 |
platelet/endothelial cell adhesion molecule (CD31 antigen) | PECAM1 | 3.15 | 0.25 | 0.96 | 0.26 | 3.26 | 0.25 | 1.08 | 0.83 | -1.02 | 0.67 |
selectin E (endothelial adhesion molecule 1) | SELE | 1.60 | 1.22 | 0.33 | 1.27 | 4.86 | 0.30 | 1.03 | 0.83 | 1.10 | 0.67 |
syndecan 2 | SDC2 | 2.16 | 0.34* | 0.59 | 0.37* | 3.66 | 0.17* | -1.12 | 1.40 | 1.01 | 0.76 |
syndecan 4 | SDC4 | 3.34 | 0.31* | 1.16 | 0.30 | 2.95 | 0.33 | 1.01 | 1.21 | 1.13 | 0.84 |
vascular cell adhesion molecule 1 | VCAM1 | 2.34 | 0.20* | 0.91 | 0.24 | 2.62 | 0.23 | 1.24 | 1.43 | -1.02 | 0.83 |